PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: ECON Corporate Services / InvestorIdeas.com™

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aethlon CEO to Provide Congressional Testimony - Aethlon Medical, Inc. (OTCBB: AEMD) announced that it's Chairman and CEO, James A. Joyce, will testify today before The House Committee on Homeland Security, Subcommittee on Emergency Preparedness, Science, and Technology.
Aethlon CEO to Provide Congressional Testimony

 

NewswireToday - /newswire/ - San Diego, CA, United States, 2005/07/12 - Aethlon Medical, Inc. (OTCBB: AEMD) announced that it's Chairman and CEO, James A. Joyce, will testify today before The House Committee on Homeland Security, Subcommittee on Emergency Preparedness, Science, and Technology..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Military/Defense/Homeland Security Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The hearing will begin at 9:30am (EST) and is entitled "Project BioShield; Linking Bioterrorism Threats and Countermeasure Procurement to Enhance Terrorism Preparedness." The Committee will provide public access via the World Wide Web at the U.S. House of Representatives at homeland.house.gov or through the Library of Congress at house.gov.

About Aethlon Medical

Aethlon Medical is pioneering the development of viral filtration devices to treat drug and vaccine resistant pathogens. The market focus is the treatment of the Human Immunodeficiency Virus (HIV), Hepatitis-C (HCV), and Biological Weapon Threats. Aethlon has an experienced management team, which receives support and guidance from globally recognized science advisors representing the infectious disease, biowarfare, and dialysis industries. Clinical Trials to treat HIV and HCV patients in India are scheduled to begin in the coming months, and U.S. clinical studies are expected to begin later this year.

Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors.

In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.

Source: Aethlon Medical, Inc.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Military/Defense/Homeland Security Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: ECON Corporate Services / InvestorIdeas.com™

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Military/Defense/Homeland Security articles,
CATCH Visitors via Your Competitors Announcements!


Aethlon CEO to Provide Congressional Testimony

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Anne Hoverste 
858-459-7800
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ECON Corporate Services / InvestorIdeas.com™ securities in any jurisdiction including any other companies listed or named in this release.

Military/Defense/Homeland Security via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ECON Corporate Services / InvestorIdeas.com™ / Company Profile


Read Military/Defense/Homeland Security Most Recent Related Newswires:

Leonardo Expands its Presence in the Philippines with New Commercial Helicopter Deliveries
Thales Delivers A Flight and Navigation Training Simulator to the Royal Malaysian Air Force
Leonardo and Hensoldt Sign Agreement to Offer Secure ‘Mode-5' Friend-or-foe Systems to the Worldwide Market
DCNS Opened its Representative Office in Bogota, Colombia and Exhibits At Colombiamar
CAE-Líder Joint Venture Strengthen its Training Partnership with Leonardo
Leonardo is Growing in the USA with the Acquisition of Daylight Solutions
Polish Armaments Group Enhances Cooperation with the Italian Company Leonardo
Boeing Selects AW139-based MH-139 for 84-aircraft US Air Force Tender
Leonardo AESA Radar to Go on North African User's Unmanned Rotorcraft
Rotary Wing Unmanned Air System - Leonardo & UK MoD Launch Phase 2 of the (RWUAS) Demonstrator Programme
Leonardo to Upgrade Italian Navy NH90s with Mode 5 IFF Technology in €11M Contract
Leonardo Delivers First Italian Navy NH90 MITT Tactical Transport Helicopter
Siham Al Khaleej Technology, Leonardo and MBDA Present their New 'SIHAM³' Combined Anti-Air and Anti-Surface Weapon System At IDEX 2017
French Army to Use Leonardo AESA Radar for the SDT Program (Tactical Drone System)
DCNS Exhibits At IDEX-NAVDEX in Abu Dhabi, UAE

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)